Swedish Real Estate Stock News

BioGaia (OM:BIOG B) has just wrapped up FY 2025 with fourth quarter revenue of SEK440.6 million and EPS of SEK0.98, capping a year in which trailing twelve month revenue reached about SEK1.5 billion and EPS came in at SEK3.29. The company has seen quarterly revenue move from SEK364.8 million in Q4 2024 to SEK440.6 million in Q4 2025, while EPS shifted from SEK0.81 to SEK0.98 over the same period. Investors are now weighing those headline figures against a trailing net profit margin of 21.6%...

Stille (OM:STIL) closed out FY 2025 with fourth quarter revenue of SEK 174.9 million and basic EPS of SEK 3.37, setting the tone for how the full year is being judged. Over recent periods, the company has seen quarterly revenue range from SEK 124.7 million to SEK 174.9 million and basic EPS move from SEK 0.10 in Q3 2025 to SEK 3.37 in Q4 2025, while trailing twelve month EPS stood at SEK 6.20 on revenue of SEK 567.6 million. With a trailing net margin of 9.8% and a clear focus on...

If you are looking at EQT and wondering whether the current share price still offers value, this article will walk you through what the numbers actually say about the stock. The share price last closed at SEK 290.30, with returns of 2.0% over 7 days, a 19.4% decline over 30 days, and returns of 20.7% over 3 years and 21.8% over 5 years that give useful longer term context. Recent coverage of EQT has focused on how the stock's shorter term pullback sits against its longer term record. This...

Camurus AB reported its fourth-quarter and full-year 2025 results, with full-year sales rising to SEK 2,265.38 million and net income to SEK 735.57 million, while issuing 2026 guidance for revenues of SEK 2.60–2.90 billion and operating result of SEK 0.90–1.20 billion. Alongside these results, Camurus highlighted 2025 milestones including EU and UK approvals for Oxyesa in acromegaly and progress in long-acting metabolic therapies, underlining how its product pipeline and regulatory traction...

Investment AB Latour (OM:LATO B) has wrapped up FY 2025 with Q4 revenue of SEK7.4b and basic EPS of SEK2.50, while the trailing twelve months show revenue of SEK28.1b and EPS of SEK7.69 against a backdrop of weaker earnings compared with the prior year and a lower net margin of 17.5% versus 23.8%. Over recent quarters, revenue has moved from SEK7.0b in Q4 2024 to SEK7.4b in Q4 2025, with quarterly EPS shifting from SEK2.29 to SEK2.50 as the twelve month EPS line eased from SEK9.65 to SEK7.69...

What recent performance says about Embracer Group (OM:EMBRAC B) Embracer Group (OM:EMBRAC B) has seen its share price move sharply in different directions, with a 19% gain over the past week and a 38% decline over the past 3 months. This places recent momentum in contrast with a weaker medium term trend. See our latest analysis for Embracer Group. At a share price of SEK54.47, Embracer Group’s sharp 18.7% 7 day share price return comes after a weaker stretch, with the 1 year total shareholder...

As global markets navigate a period of mixed performance, with technology stocks facing challenges and value-oriented segments gaining traction, investors are keenly observing the shifts in economic indicators such as cooling U.S. labor data and fluctuating manufacturing activity. In this context, identifying undervalued stocks can be particularly appealing as they may offer potential opportunities for growth amidst the broader market volatility and sector rotations.

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

If you are wondering whether Skandinaviska Enskilda Banken shares still offer value after a long run in the market, you are in the right place for a closer look at what the current price might be baking in. The stock last closed at SEK191.0, with returns of a 1.3% decline over 7 days, a 4.8% decline over 30 days and a 3.5% decline year to date, while the 1 year return stands at 24.6%, the 3 year return at 83.8% and the 5 year return at 176.3%. Recent news coverage around Skandinaviska...

If you are wondering whether Telefonaktiebolaget LM Ericsson’s current share price fairly reflects its potential, you are not alone. Many investors are asking the same question before making their next move. The stock last closed at SEK 97.2, with returns of a 2.3% decline over 7 days, 11.7% over 30 days, 10.1% year to date, 18.1% over 1 year, 81.0% over 3 years and 5.8% over 5 years. This gives investors plenty to think about in terms of changing sentiment and risk. Recent news coverage...

Vimian Group (OM:VIMIAN) is back in focus after its fourth quarter and full year 2025 earnings, where double digit revenue and adjusted EBITDA growth, along with a higher full year net income, drew fresh investor attention. See our latest analysis for Vimian Group. The earnings release and earlier 2025 earnings call seem to have reset sentiment, with the latest move to SEK27.94 coming after a 1 day share price return of 11.14%, against a weaker 1 year total shareholder return of 37% and a...

What the Lovable partnership could mean for Sinch Sinch (OM:SINCH) has just announced a partnership with Lovable, integrating its communications tools into the Lovable Cloud to support AI-built applications and production workloads across email, messaging, and voice. The collaboration starts with Sinch's Mailgun platform for email and could broaden into wider omnichannel services as Lovable users move from early prototypes to live customer facing products. See our latest analysis for...

As the European markets continue to show resilience amid global volatility, optimism about the eurozone economy has supported investor sentiment, with major indices like Germany's DAX and France's CAC 40 posting gains. In this environment of cautious optimism and stable interest rates from the European Central Bank, identifying undervalued stocks becomes crucial for investors looking to capitalize on potential market opportunities.

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

With its stock down 19% over the past month, it is easy to disregard Generic Sweden (STO:GENI). But if you pay close...

Pricer AB (publ) ( STO:PRIC B ) shareholders won't be pleased to see that the share price has had a very rough month...

The nature of investing is that you win some, and you lose some. And unfortunately for Meko AB (publ) ( STO:MEKO...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Key Insights Significant insider control over Vestum implies vested interests in company growth 53% of the business is...

With the business potentially at an important milestone, we thought we'd take a closer look at IRLAB Therapeutics AB...

JM AB (publ) ( STO:JM ) has announced that on 23rd of April, it will be paying a dividend ofSEK2.00, which a reduction...

There's been a notable change in appetite for Asker Healthcare Group AB ( STO:ASKER ) shares in the week since its...

It is hard to get excited after looking at Vertiseit's (STO:VERT B) recent performance, when its stock has declined 28...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...